Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Stevens

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Risk Management (New York, N.Y.)|June 7, 1992
Stress in CaliforniaH J Stevens
Current Neurology and Neuroscience Reports|July 11, 2006
Antiepileptic therapy in patients with central nervous system malignanciesGlen H J Stevens
Neurology|October 9, 2002
Main trunk tibial neuropathiesCornelia Drees, Asa J Wilbourn, Glen H J Stevens
Psychopharmacology|January 1, 1981
Differences in presynaptic alpha-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserinH Schoemaker, H H Berendsen, H J Stevens, et al.
Pharmaceutical Research|May 5, 1999
Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilizationG C Na, H J Stevens, B O Yuan, et al.
The Journal of Hand Surgery|June 22, 2001
Prospective randomized trial of open versus percutaneous surgery for trigger digitsE C Gilberts, W H Beekman, H J Stevens, et al.
International Journal of Surgical Pathology|September 17, 2002
Brain-invasive solitary fibrous tumor of the meninges: report of a caseElias A Castilla, Richard A Prayson, Glen H J Stevens, et al.
British Journal of Anaesthesia|July 13, 2006
One-lung ventilation in a patient with an organizing empyema and severe idiopathic pulmonary fibrosisJ Pfitzner, H J Stevens, V Rao, et al.
Pharmaceutical Research|May 5, 1999
Cloud point of nonionic surfactants: modulation with pharmaceutical excipientsG C Na, B O Yuan, H J Stevens, et al.
Expert Review of Anticancer Therapy|September 24, 2013
Recurrent or refractory primary central nervous lymphoma: therapeutic considerationsSaurabh Dahiya, Erin S Murphy, Samuel T Chao, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Risk Management (New York, N.Y.)|June 7, 1992
Stress in CaliforniaH J Stevens
Current Neurology and Neuroscience Reports|July 11, 2006
Antiepileptic therapy in patients with central nervous system malignanciesGlen H J Stevens
Neurology|October 9, 2002
Main trunk tibial neuropathiesCornelia Drees, Asa J Wilbourn, Glen H J Stevens
Psychopharmacology|January 1, 1981
Differences in presynaptic alpha-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserinH Schoemaker, H H Berendsen, H J Stevens, et al.
Pharmaceutical Research|May 5, 1999
Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilizationG C Na, H J Stevens, B O Yuan, et al.
The Journal of Hand Surgery|June 22, 2001
Prospective randomized trial of open versus percutaneous surgery for trigger digitsE C Gilberts, W H Beekman, H J Stevens, et al.
International Journal of Surgical Pathology|September 17, 2002
Brain-invasive solitary fibrous tumor of the meninges: report of a caseElias A Castilla, Richard A Prayson, Glen H J Stevens, et al.
British Journal of Anaesthesia|July 13, 2006
One-lung ventilation in a patient with an organizing empyema and severe idiopathic pulmonary fibrosisJ Pfitzner, H J Stevens, V Rao, et al.
Pharmaceutical Research|May 5, 1999
Cloud point of nonionic surfactants: modulation with pharmaceutical excipientsG C Na, B O Yuan, H J Stevens, et al.
Expert Review of Anticancer Therapy|September 24, 2013
Recurrent or refractory primary central nervous lymphoma: therapeutic considerationsSaurabh Dahiya, Erin S Murphy, Samuel T Chao, et al.
Pageof 5